Delivery Order SPE2DE21D0017-SPE2D626F46YM

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order for BinaxNOW COVID-19 antigen test cards valued at $1,005.05 on December 18, 2025, with an ultimate completion date of January 12, 2026. The contract is fixed-price with economic price adjustment pricing and carries no set-aside designation. Performance will take place in Lake Mary, Florida. Funding originates from the Defense Logistics Agency's Medical Supply Chain, a defense-focused...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on December 4, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. This fixed-price delivery order with economic price adjustment will be performed in Lake Mary, Florida, and is funded through the Defense Logistics Agency's Medical Supply Chain division. The contract carries no small business set-aside designation and represents an ongoing procurement of...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,608.08 for BinaxNOW COVID-19 antigen test cards. The contract, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a fixed-price structure with economic price adjustment provisions. Funding originates from the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies...

The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $402,020 delivery order to provide Abbott BinaxNOW COVID-19 antigen test cards. The fixed price with economic price adjustment contract has a period of performance from August 16, 2023 to September 7, 2023. Place of performance will be Abbott's facility located in Lockhart, Florida. The BinaxNOW cards are rapid antigen tests used to detect current COVID-19...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order for BinaxNOW COVID-19 Antigen Test Cards with a ceiling value of $2,010.10. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of February 10, 2026. This delivery order was issued without set-aside designation on January 20, 2026, and will be performed in Lake Mary, Florida. Funding originates from...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on December 3, 2025, for BinaxNOW COVID-19 antigen test cards. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by December 24, 2025, with performance taking place in Lake Mary, Florida. The award was issued by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for managing...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on December 17, 2025, for BinaxNOW COVID-19 antigen test cards. The contract operates under a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of January 9, 2026. The award was issued by the Defense Logistics Agency Medical Supply Chain, which serves the Department of Defense healthcare procurement mission. No small...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...

Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order for BinaxNOW COVID-19 antigen test cards valued at $3,015.15 under a fixed-price contract with economic price adjustment provisions. The award was issued on November 20, 2025, with an ultimate completion date of December 12, 2025, and will be performed in Lockhart, Florida. The contract carries no set-aside designation and was issued under a full and open competition basis by the...